Related Experiment Video
Updated: Apr 29, 2026

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
Published on: January 10, 2025
GENDER-RESPONSIVE DRUG COURT TREATMENT: A Randomized Controlled Trial
Nena Messina1, Stacy Calhoun1, Umme Warda1
1University of California, Los Angeles.
Abstract:
This pilot study compared outcomes for 94 women offenders in San Diego County, California, who participated in four drug court programs. Women were randomized to gender-responsive (GR) programs using Helping Women Recover and Beyond Trauma or standard mixed-gender treatment. Data were collected at program entry, during treatment, and approximately 22 months after treatment entry. Bivariate and multivariate analyses were conducted. Results showed that GR participants had better in-treatment performance, more positive perceptions related to their treatment experience, and trends indicating reductions in posttraumatic stress disorder (PTSD) symptomology. Both groups improved in their self-reported psychological well-being and reported reductions in drug use (p < .06) and arrest (a diagnosis of PTSD was the primary predictor of reductions in rearrest, p < .04). Findings show some beneficial effects of adding treatment components oriented toward women's needs. Significant questions remain, particularly around PTSD and whether it should be targeted to improve substance use outcomes for women.
Related Concept Videos
Dosage Regimens: Designs and Approaches
Drug Abuse and Addiction: Pharmacological Phenomena
Drug Control Governance: Regulatory Bodies and Their Impact
Factors Affecting Drug Response: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Drug Dependence

